HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Folke Lindgärde Selected Research

Orosomucoid (Seromucoid)

2/2009Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study.
3/2006Occupation, marital status, and low-grade inflammation: mutual confounding or independent cardiovascular risk factors?
2/2005Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.
12/2004Risk of treatment of peripheral arterial disease is related to inflammation-sensitive plasma proteins: a prospective cohort study.
7/2004Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study.
8/2003Inflammation-sensitive plasma proteins are associated with future weight gain.
7/2003Risk of myocardial infarction in relation to plasma levels of homocysteine and inflammation-sensitive proteins: a long-term nested case-control study.
12/2002Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Folke Lindgärde Research Topics

Disease

14Inflammation (Inflammations)
02/2009 - 12/2002
7Myocardial Infarction
02/2009 - 02/2003
6Cardiovascular Diseases (Cardiovascular Disease)
03/2006 - 12/2002
3Stroke (Strokes)
02/2009 - 02/2003
2Obesity
06/2010 - 08/2004
2Pain (Aches)
09/2005 - 12/2004
1Insulin Resistance
06/2010
1Body Weight (Weight, Body)
06/2010
1Type 2 Diabetes Mellitus (MODY)
06/2010
1Glucose Intolerance
06/2010
1Heart Failure
02/2009
1Atherosclerosis
06/2007
1Hypercholesterolemia
01/2007
1Hypertriglyceridemia
01/2007
1Hyperinsulinism (Hyperinsulinemia)
11/2006
1Peripheral Arterial Disease
12/2004
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2004
1Overweight
08/2004
1Coronary Disease (Coronary Heart Disease)
07/2004
1Abdominal Aortic Aneurysm
02/2004
1Weight Gain
08/2003
1Hypertension (High Blood Pressure)
12/2002

Drug/Important Bio-Agent (IBA)

13Blood Proteins (Serum Proteins)IBA
02/2009 - 12/2002
8Fibrinogen (Factor I)FDA Link
02/2009 - 12/2002
8Orosomucoid (Seromucoid)IBA
02/2009 - 12/2002
8HaptoglobinsIBA
02/2009 - 12/2002
8Ceruloplasmin (Ferroxidase)IBA
02/2009 - 12/2002
4Proteins (Proteins, Gene)FDA Link
03/2006 - 12/2002
2Glucose (Dextrose)FDA LinkGeneric
06/2010 - 11/2006
2LipidsIBA
01/2007 - 12/2003
2Triglycerides (Triacylglycerol)IBA
01/2007 - 10/2004
2alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
12/2004 - 07/2004
1Insulin (Novolin)FDA Link
06/2010
1InterleukinsIBA
06/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010
1Interleukin-6 (Interleukin 6)IBA
06/2010
1CytokinesIBA
06/2010
1Complement C3 (C3 Complement)IBA
06/2007
1Complement System Proteins (Complement)IBA
06/2007
1CholesterolIBA
01/2007
1Fatty Acids (Saturated Fatty Acids)IBA
11/2006
1Biomarkers (Surrogate Marker)IBA
10/2004
1LeptinIBA
10/2004
1Biological ProductsIBA
10/2004
1HomocysteineIBA
07/2003